Interpretation of cancer mutations using a multiscale map of protein systems
Fan Zheng,Marcus R Kelly,Dana J Ramms,Marissa L Heintschel,Kai Tao,Beril Tutuncuoglu,John J Lee,Keiichiro Ono,Helene Foussard,Michael Chen,Kari A Herrington,Erica Silva,Sophie N Liu,Jing Chen,Christopher Churas,Nicholas Wilson,Anton Kratz,Rudolf T Pillich,Devin N Patel,Jisoo Park,Brent Kuenzi,Michael K Yu,Katherine Licon,Dexter Pratt,Jason F Kreisberg,Minkyu Kim,Danielle L Swaney,Xiaolin Nan,Stephanie I Fraley,J Silvio Gutkind,Nevan J Krogan,Trey Ideker,Marcus R. Kelly,Dana J. Ramms,Marissa L. Heintschel,John J. Lee,Kari A. Herrington,Sophie N. Liu,Rudolf T. Pillich,Devin N. Patel,Michael K. Yu,Jason F. Kreisberg,Danielle L. Swaney,Stephanie I. Fraley,J. Silvio Gutkind,Nevan J. Krogan
DOI: https://doi.org/10.1126/science.abf3067
IF: 56.9
2021-10-01
Science
Abstract:Mapping protein interactions driving cancer Cancer is a genetic disease, and much cancer research is focused on identifying carcinogenic mutations and determining how they relate to disease progression. Three papers demonstrate how mutations are processed through networks of protein interactions to promote cancer (see the Perspective by Cheng and Jackson). Swaney et al . focus on head and neck cancer and identify cancer-enriched interactions, demonstrating how point mutant–dependent interactions of PIK3CA, a kinase frequently mutated in human cancers, are predictive of drug response. Kim et al . focus on breast cancer and identify two proteins functionally connected to the tumor-suppressor gene BRCA1 and two proteins that regulate PIK3CA. Zheng et al . developed a statistical model that identifies protein networks that are under mutation pressure across different cancer types, including a complex bringing together PIK3CA with actomyosin proteins. These papers provide a resource that will be helpful in interpreting cancer genomic data. —VV
multidisciplinary sciences